Results 231 to 240 of about 1,357,862 (296)

Concurrent malignant phyllodes tumor and invasive ductal carcinoma in a young female: a rare case report. [PDF]

Ann Med Surg (Lond)
Jehangir AM, Mehmood N, Khan MS, Abrar Z, Riaz AA, Antar M, Khan A.   +6 more
europepmc   +1 more source

A Review of Linear Stapled‐Sutured Intrathoracic Oesophago‐Gastric Anastomosis by a Single Surgeon Over Three Decades

ANZ Journal of Surgery, EarlyView.
ABSTRACT This paper describes the technique of performing an intrathoracic linear stapled/sutured anastomosis between the oesophagus and gastric conduit. It analyses the outcome from a single surgeon working at two co‐located hospitals. Method A retrospective review of prospectively collected data was performed.
Matilda Anderson, Enoch Wong, Jan Goonawardena, Peter Bird, Richard Cade, Akhtar H. Sayed Hassen   +5 more
wiley   +1 more source

Methylglyoxal-derived glycated albumin enhances the stemness potential of invasive ductal carcinoma-derived breast cancer stem-like cell line KAIMRC1. [PDF]

Oncol Lett
Aldawood M, Alamoudi MK, Alsaleh AA, Alharbi N, Huwaizi S, Alroshody R, Ali R, Almeer R, Matou-Nasri S.   +8 more
europepmc   +1 more source

Invasive ductal carcinoma (histology)

, 2020
openaire   +1 more source

Cancer pain: current practice and emerging targets

British Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye, Marcin Chwistek, Zhiting Gong, Vanessa Uzonwanne, Xiaojie Shi, Arpad Szallasi   +5 more
wiley   +1 more source

Sonographic Correlations With Histological Grade and Biomarker Profiles in Breast Invasive Ductal Carcinoma. [PDF]

Cancer Rep (Hoboken)
Moradi G, Ahmadinejad N, Zarei D, Sadighi N.   +3 more
europepmc   +1 more source

Targeting KRAS for cancer therapy

British Journal of Pharmacology, EarlyView.
In recent years, therapeutics targeted against KRAS proto‐oncogene GTPase (KRAS)‐mutant cancers have seen significant progress. Herein we outline the biology and epidemiology of KRAS alterations at the lineage and allele levels, reviewing the clinical evidence for KRASG12C inhibition from the discovery of the recessive switch pocket to sotorasib ...
Jianlong Jia, Ruonan Liu, Tonia A. Adamide, Isis E. Fernandez, Georgios T. Stathopoulos   +4 more
wiley   +1 more source

Invasive ductal carcinoma at the site of a cosmetic nipple piercing. [PDF]

J Surg Case Rep
Bui J, Chalom T, Nathanson SD, Schwartz TL, Hunt K, Alkhoory W, Xu Z.   +6 more
europepmc   +1 more source

Ductal carcinoma in situ with invasive ductal component

, 2012
openaire   +1 more source

Extracellular vesicles in pharmacology: Innovations in drug delivery and therapeutic applications in cancer

British Journal of Pharmacology, EarlyView.
Extracellular vesicles (EVs) are a diverse population of membrane nanoparticles secreted by nearly all cell types, playing a key role in intercellular communication by transferring bioactive macromolecular cargo. In cancer, EVs shape both the local tumour microenvironment and distant premetastatic niches.
Evangelia Pantazaka, Georgios Sivvas, Evangelia Papadimitriou, Constantinos M. Mikelis   +3 more
wiley   +1 more source